MetLife Investment Management, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$4,726,331
-19.2%
125,234
-2.5%
0.04%
-15.9%
Q2 2023$5,849,084
+8.1%
128,382
-3.7%
0.04%
+10.0%
Q1 2023$5,408,353
-20.5%
133,342
-0.1%
0.04%
-25.9%
Q4 2022$6,801,896
-6.9%
133,449
-1.6%
0.05%
-14.3%
Q3 2022$7,304,493
-17.3%
135,620
-1.4%
0.06%
-12.5%
Q2 2022$8,836,571
-15.6%
137,577
+1.9%
0.07%
+4.3%
Q1 2022$10,468,598
+11.5%
135,009
+23.5%
0.07%
-12.7%
Q4 2021$9,387,462
+4.9%
109,360
-1.7%
0.08%
-4.8%
Q3 2021$8,950,894
-3.3%
111,288
-3.2%
0.08%
-5.7%
Q2 2021$9,253,556
-7.6%
114,951
-3.2%
0.09%
-7.4%
Q1 2021$10,013,520
+2.0%
118,728
-3.0%
0.10%
-5.0%
Q4 2020$9,821,055
-3.6%
122,396
-3.4%
0.10%
-10.7%
Q3 2020$10,187,847
-10.3%
126,683
-4.0%
0.11%
-13.2%
Q2 2020$11,361,928
+6.3%
131,962
+0.3%
0.13%
-14.6%
Q1 2020$10,684,766
-5.8%
131,602
-3.0%
0.15%
+28.0%
Q4 2019$11,341,213
-6.7%
135,628
-2.4%
0.12%
-15.1%
Q3 2019$12,153,169
+13.5%
138,941
+6.2%
0.14%
+16.8%
Q2 2019$10,710,718
-2.8%
130,778
-3.5%
0.12%
-4.0%
Q1 2019$11,019,782
+18.3%
135,528
-4.2%
0.12%
+6.0%
Q4 2018$9,315,965
-16.4%
141,537
-2.1%
0.12%
-0.8%
Q3 2018$11,142,974
+4.1%
144,545
-0.3%
0.12%
-6.3%
Q2 2018$10,709,000
-44.9%
145,024
-51.5%
0.13%
-45.0%
Q1 2018$19,453,000
+93.3%
299,090
+92.8%
0.23%
+100.9%
Q4 2017$10,064,000155,1000.11%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders